BENGALURU: The health ministry’s Central Drugs Standard Control Organisation, the national regulatory body for Indian pharmaceuticals and medical devices, has permitted Ayurveda, homeopathy and siddha practitioners to conduct research at covid-19 quarantine centres to better understand the disease.
In its notification last week, the Ayush ministry said, “Indian traditional medicines have wide potential for usage in such conditions owing to their longstanding use in the community, ancient references and clinical efficacy.
Therefore, it is felt necessary to make serious efforts for development of drugs based on any Ayush systems recognised under the Drugs and Cosmetics Act, 1940.